Citigroup Inc Anika Therapeutics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 11,523 shares of ANIK stock, worth $195,084. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,523

Previous 3,355 243.46%

Holding current value

$195,084

Previous $84,000 238.1%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$24.25 - $28.75 $198,074 - $234,830	8,168 Added 243.46%	11,523 $284,000
Q2 2024 Aug 12, 2024	BUY	$24.57 - $28.47 $12,383 - $14,348	504 Added 17.68%	3,355 $84,000
Q1 2024 May 10, 2024	BUY	$21.95 - $26.42 $15,891 - $19,128	724 Added 34.04%	2,851 $72,000
Q4 2023 Feb 09, 2024	BUY	$18.47 - $23.3 $37,604 - $47,438	2,036 Added 2237.36%	2,127 $48,000
Q3 2023 Nov 09, 2023	SELL	$16.98 - $26.1 $338,326 - $520,042	-19,925 Reduced 99.55%	91 $1,000
Q2 2023 Aug 10, 2023	SELL	$25.16 - $28.86 $288,459 - $330,879	-11,465 Reduced 36.42%	20,016 $520,000
Q1 2023 May 11, 2023	BUY	$25.91 - $32.1 $230,210 - $285,208	8,885 Added 39.32%	31,481 $904,000
Q4 2022 Feb 09, 2023	SELL	$23.85 - $31.91 $281,048 - $376,027	-11,784 Reduced 34.28%	22,596 $668,000
Q3 2022 Nov 10, 2022	BUY	$21.74 - $24.68 $205,269 - $233,028	9,442 Added 37.86%	34,380 $818,000
Q2 2022 Aug 10, 2022	BUY	$20.4 - $25.53 $72,603 - $90,861	3,559 Added 16.65%	24,938 $557,000
Q1 2022 May 12, 2022	SELL	$24.7 - $36.54 $287,829 - $425,800	-11,653 Reduced 35.28%	21,379 $537,000
Q4 2021 Feb 10, 2022	BUY	$35.83 - $45.03 $442,715 - $556,390	12,356 Added 59.76%	33,032 $1.18 Million
Q3 2021 Nov 10, 2021	BUY	$38.75 - $44.47 $801,195 - $919,461	20,676 New	20,676 $880,000

Others Institutions Holding ANIK

# of Institutions

126

Shares Held

11.4M

Call Options Held

200

Put Options Held

100

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $247M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account